Cure My Disease

Don't miss your cure!

 Log in / Sign up

Team approach may cut complications for patients sent home on oxygen

NCT ID NCT07782892

Disease control Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial tests whether having an emergency advanced practice nurse work alongside a physician, instead of a physician alone, improves the process of sending oxygen-dependent patients home from the emergency department. Adult patients eligible for a home oxygen pathway are randomly assigned to either team-based or physician-only management. The study tracks organizational problems (like delays or errors) and clinical deterioration over 28 days, and also interviews patients and staff about their experiences. The goal is to see if the team approach makes home discharge safer and more efficient.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
An organizational intervention: management by an emergency advanced practice nurse (APN) and physician team, compared to physician-alone management, for the home discharge of oxygen-dependent patients.
What this could lead to
If effective, this team-based approach could reduce complications and improve the experience of patients sent home on oxygen, making this care pathway safer and more sustainable.
What could go wrong
This is a single-center trial with a modest sample size, and the primary outcome focuses on organizational issues rather than direct clinical outcomes. Results may not generalize to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 170 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Oct 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient (\>= 18 years) * Affiliated to a social health insurance scheme * Able to understand the objectives and risks of the research and to give dated, signed informed consent * Oxygen-dependent patient eligible for the Oxy-Urg pathway, meeting all of the following: * Stable for more than 12 hours on oxygen therapy in the emergency department * Oxygen requirement \<= 2 L/min (no upward change for 12 hours) * Not socially isolated (relatives able to readily help the patient, living geographically close) * Residing within the provider's geographical area (Bas-Rhin department) * No known pregnancy at inclusion Exclusion Criteria: * Clinical condition requiring hospitalization (decided by the senior physician, per standard of care) * Patient's refusal to enter the pathway * Patient managed outside the emergency APN's working hours * End-of-life patient * Unable to give informed consent (including insufficient understanding of French) * Subject in an exclusion period * Subject under legal protection * Subject under guardianship or curatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute respiratory conditions requiring oxygen therapy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute respiratory conditions requiring oxygen therapy Advanced practice nursing Emergency service, hospital Home care services Home oxygen therapy Patient discharge

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpitaux Universitaires de Strasbourg

    Strasbourg, Grand Est, 67000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.